The 90 Mil won't last long once the lawsuits start rolling not to mention the legal issue they face trying to prove their product was not at fault. FDA will find that the medication was administered outside the boundaries for which it was tested/approved. AFFY will not be found at fault ciminally however FDA will require AFFY to provide additional testing to prove the reaction was from a non approved use which will then require a new warning label. This will take a year to perform and document which will dry up AFFY's outstanding cash and with no revenue coming in will eventually resort to BK or being bought out at a cheap price.
Don't the lawyers need to prove it was omonty's that caused the anaphylactic reactions before settlement can be reached? That's alot of proving to be done if litigation does happen. Affymax has clinical data in their existing legal box, FDA approval, 25000 cases where patients benifited.
Get some updated #'s. as of Feb 28th. 67 in cash, 11 in debt, 10 spent on layoffs. and 33 million in bad contracts(which will go away in BK, Hence a max value of $1.25 a share as of Feb 28th. Lower as of Today.